Trials / Unknown
UnknownNCT00480961
Congestive Heart Failure Surgical Treatmment With Autologous Stem Cell Therapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study was designed to test the safety and effectiveness of autologous stem cell graft in the myocardium of patients with refractory Congestive Heart Failure (CHF) with ischemic etiology. Cellular implantation will take place during off-pump revascularization surgery or during an ad hoc procedure using a mini-thoracotomy access.
Detailed description
Primary target: determine the safety of introducing CD 34+ autologous progenitor cells (centrally grafted or mobilized in peripheral blood) in the myocardium of ischemic cardiac disease patients. Secondary target: determine clinical effects of grafted cells on remodeling pathology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | intramiocardiac autograft of autologous stem cells |
Timeline
- Start date
- 2007-05-01
- First posted
- 2007-06-01
- Last updated
- 2007-06-01
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00480961. Inclusion in this directory is not an endorsement.